Traditional in vivo devices fabricated to be used as implantation devices included sutures, plates, pins, screws, and joint replacement implants. Also, akin to developments in regenerative medicine and drug delivery, there has been the pursuit of less conventional in vivo devices that demand complex architecture and composition, such as tissue scaffolds. Commercial means of fabricating traditional devices include machining and moulding processes. Such manufacturing techniques impose considerable lead times and geometrical limitations, and restrict the economic production of customized products. Attempts at the production of non-conventional devices have included particulate leaching, solvent casting, and phase transition. These techniques cannot provide the desired total control over internal architecture and compositional variation, which subsequently restricts the application of these products. Consequently, several parties are investigating the use of freeform layer manufacturing techniques to overcome these difficulties and provide viable in vivo devices of greater functionality. This paper identifies the concepts of rapid manufacturing (RM) and the development of biomanufacturing based on layer manufacturing techniques. Particular emphasis is placed on the development and experimentation of new materials for bio-RM, production techniques based on the layer manufacturing concept, and computer modelling of in vivo devices for RM techniques.
INTRODUCTION
of donors, limited amount of surplus tissue, high rejection potential, and complications as a result of donor site morbidity, patient distress, potential of In vivo devices are artificial devices put into the human body or living organisms to replace or restore transmission of infectious diseases, reduced speed of treatment and quality of life, and increased life functions of living tissues [1] . The manufacture of in vivo devices for bone replacement was conceived in expectancy have led to thousands of patients spending the rest of their lives before they receive an organ the 1950s by Sir John Charnley [2] . The concept of implantation devices was partly invoked by the from a suitable donor [3] [4] [5] [6] [7] . Approximately onequarter of patients in need of organ transplants in restrictions of restoration by transplantation. Autografting (transplantation of surplus tissue, typically the United States die while waiting for a suitable donor [8] . Such figures and patient distress and poor bone, from one location to another in the same patient) and allografting (transplantation of a tissue quality of life have further driven the continued investigation of synthetic or artificial replacements. or organ from a donor to the patient, typically the The construction and composition of implant kidney or heart) both require additional procedures devices for tissue replacement or regeneration are and incur higher cost and risk of infection/transfer dictated by the requirements of their application, i.e. of disease, and they are fundamentally limited by the relatively solid products for bone replacement or amount of surplus tissue in the desired morphology deliberately porous structures for tissue growth or the shortage of donors. An increase in the shortage scaffolds, but also by the restrictions of their pro- organs and is widely foreseen as one of the next great Zirconia (ZrO 2 ) breakthroughs in medical treatment. Subsequently, Carbon of a material to perform with an appropriate tissue response, in a specific condition. This is a most critical characteristic and precludes all other selection physical, and mechanical properties. These propercriteria. To achieve the required biocompatibility, ties are not only determined by the inherent material two routes are often employed:
properties but also by the implant design and its internal architecture [19] [20] [21] . (a) the fabrication of in vivo devices using off-theshelf materials with application of a suitable 2.2 Types of in vivo device biocompatible coating layer; (b) the fabrication of in vivo devices using biocom-Increased life expectancy and greater healthcare patible materials.
capabilities has led to the development of a large number and diverse range of in vivo devices. This section only discusses the latter. The materials Currently, in vivo devices such as pins, plates, rods, used to fabricate in vivo devices may be grouped into screws, drug delivery devices, valves, sutures, grafts, metals, ceramics, polymers, and composites thereof. and fixations are produced to assist in the treatment Biomaterials have been further classified on the basis and recuperation of patients for a variety of conof their function, such as bioinert, bioactive, bioditions. Subsequently, in vivo devices serve a variety stable, and biodegradable [14, 15] . No one material of functions. These may include the replacement of is suitable for all biomaterial applications. Advana damaged tissue or organ, provision of temporary tages and limitations of each individual material and or permanent mechanical support, and the conthe suitability of materials for specific applications trolled release of drugs in relation to the individual have been studied through laboratory experimentpatient and treatment. An ideal would be for one ation and clinical investigations [16] . Table 1 lists a device to serve a combination of functions, e.g. a variety of commonly used biomaterials.
bone replacement implant would provide comple-The surface and structural compatibility of a material refers to the suitability of its chemical, biological, mentary geometry according to the bone defect site, a Young's modulus nearly equal to the local bone, of fixation components, the indirect manufacture of surgical guides and templates [41] , fit evaluation of selective designed porosity to facilitate growth of tissue into the device, and osteogenic stem cell deliv-implants [42, 43] , and as an enabling process in facial prosthetics [44] . Some of the benefits (i.e. increased ery for faster integration of surrounding tissue. Such ideals would place great demands on manufacturing speed, customization, and efficiency) that have been realized through this work have prompted continued process technology.
To date, conventional in vivo device fabrication research and further applications of layer manufacturing technologies, leading to the investigation of techniques have included compression/injection/ melt moulding [22] [23] [24] , fibre bonding [25, 26] , phase their use for the direct production of medical devices. RM is the use of layer manufacturing processes to separation [3, 5, 11] , solvent casting/particulate leaching [3, 27, 28] , membrane lamination [26] , deliver finished parts directly from digital data. The concept of RM offers a compelling list of benefits. gas foaming/high-pressure processing [29] , the lost mould method [30] , emulsion freeze drying [31] , and
With RM, tooling is eliminated, thus substantially reducing time and cost. There are other powerful combinations of these techniques [32] and machining techniques.
advantages that result from the tool-less process, including increased design freedom, heterogeneous With particular regard to scaffold structures, several production methods are capable of fabricating materials, custom products, just-in-time production, and decentralization of production [45] . foam structures. However, to date these processes have been unable to achieve all the desired charac-
In particular reference to in vivo devices, the potential advantages include the following. teristics of an optimum scaffold design -precisely controlled variation of external geometry, pore size, 1. Fewer design constraints. RM greatly reduces the pore geometry, spatial pore distribution, pore internumber of design constraints that are typically connectivity, and construction of internal channels imposed by many manufacturing processes. This which govern interactions between cells. An example is a result of the freeform nature of RM as comof the effort of these restrictions is provided by pared with conventional techniques which rely on Sachlos and Czernuszka [33] : the growth of bone tooling for their fabrication process and comtissue is limited to the external surface (less than monly limit the ability to achieve complex geo-500 mm in depth) owing to the diffusion constraints metries and inhibit the production of internal (i.e. interconnectivity, pore size, etc.) of the foam features [46, 47] . constructed using conventional techniques includ-2. Customization. The tool-less and direct nature of ing fibre bonding, solvent casting/particulate leach-RM allows the economic production of one-off ing, etc.
articles. This enables product customization while sustaining economic viability as compared with 2.3 Rapid manufacturing traditional techniques which must manufacture on mass in order to obtain economic viability. Rapid manufacturing (RM) is the direct production This would offer the potential to provide in vivo of finished goods from a layer manufacturing device, devices designed in response to specific customer known commonly as rapid prototyping (RP). Various requirements. RP techniques exist which utilize several different 3. Greater speed from image capture to finished processing fundamentals, but they all share the device. Direct device production by RM has relacharacteristic of producing an object by a sequential tively few process steps and subsequently a short layer manufacturing technique. RP processes directly lead time. RM is able to manufacture the parts in produce a physical geometry from data derived hours and days, as opposed to weeks and months from a three-dimensional representation (i.e. threefor tooling processes, as a result of the streamlined dimensional CAD), and they are characterized by process, automation, and little manual intergeneration of the geometry by an additive, layer-byaction [48]. layer manufacturing sequence, which, when in-4. Functionally graded materials (FGMs). An FGM itiated, runs unattended [34] . Further reference to RP can be defined as a material exhibiting spatially and particular processes can be found elsewhere inhomogeneous properties and microstructure. [35] . This is a possibility in RM methods by varying the RP has largely been used to date in the medical composition of two or more materials across the field for producing models for visualization and surface, interface, or bulk of the product during evaluation. RP applications have included preoperative planning and simulation [36] [37] [38] [39] [40] , preforming the build sequence. An FGM allows for the positional variation of physical properties and 3 SPECIFIC ADVANCES IN MODELLING AND characteristics. Potential applications of FGMs in DESIGN implant devices are illustrated in Fig. 1 . 5. Processing without toxic solvents. Several RM tech-Computer aided design (CAD) anatomical models niques operate without the use of solvents as are most commonly derived by reverse engineering, employed by some conventional techniques (e.g. typically by computed tomography (CT) and/or magparticulate leaching, hydrocarbon templating, netic resonance imaging (MRI) techniques [51, 52] . etc.). Incomplete removal of solvents may result CAD data are a primary process in RM and subin harmful residues that have adverse effects on sequently the full exploitation of RM as a production adherent cells, incorporated biological active method for in vivo devices is also dependent upon agents, or nearby tissues. synchronous developments in associated design 6. Controllable structure and porosity. The freeform software. Various research groups have used CAD fabrication technique utilized by RM allows for systems to conduct simulated predictive analysis the production of virtually unrestricted geoprior to production [53] . Although some of the CAD metries. Owing to the additive nature of the prodevelopments being investigated by various research cess, control over internal structure is possible.
groups are not necessarily solely aimed at the direct This would allow the internal structure and manufacture of in vivo devices, with some adapporosity to be controlled and dictated. Implant tation it may be feasible to adopt some of these techapplications may include selective areas of niques for the design of in vivo devices. However, it greater/lesser structural integrity and selective should be noted that there are ongoing discussions areas of encouraged blood flow. Absolute dictation regarding the amount of current potential appliof geometrical structure would allow highly cations for custom prosthesis. Several cases are sumcomplex customized tissue scaffolds to be promarized below. duced.
Bibb [54] reported the production of physical stereolithography (SLA, an RP technique based on Conventional RP processes and materials were the selective curing of a photosensitive resin) models developed in response to the desire of several indusof cancellous bone structures (see Fig. 2 ). The structries to be able quickly and automatically to produce ture could be controlled using commercial voxelrepresentative or functional prototypes of objects based CAD software. Emphasis was placed on the that would later be manufactured in large quantities ability of RP to generate controlled structures and by tooling processes [50] . The interest from the medithe impossibility of using any other approach. cal field has grown recently, which, after very positive
Werner et al. [55] reported the use of CAD systems results, has subsequently resulted in various investito help design anatomical hip joint endoprosthesis gations and research into the RM of in vivo products.
by applying the non-uniform rational B-spline The following sections present details on the research (NURBS) technique in describing curves and surefforts to date in the fabrication of in vivo devices using RM techniques.
faces. The redesigned endoprosthesis aimed to (a) the ability to establish a relationship between a NURBS volume and its corresponding volume model to gain structural information that would make it easier to manipulate and control a volume; (b) solving the problem of long computational time and large files generated by the marching cubes algorithm (an algorithm used to generate an STL file from volume models).
RM PROCESS TECHNOLOGIES FOR IN VIVO DEVICES
A number of research groups have investigated the utilization of layer manufacturing in the development and production of in vivo devices, including scaffolds, pins, screws, drug delivery devices, and
Fig. 2
Cancellous bond (STL file image) [22] valves. Many of these are indirect techniques where layer manufacturing is an enabling process and constitutes only part of a multiprocess chain, and do provide greater stability and minimize loosening of not fully exploit the potential of RM. Such indirect the implant.
examples include: tissue scaffolds for heart valves Zysset et al. [56] demonstrated the use of CAD for by Sodian et al. [59] , biodegradable scaffolds using predictive mechanical analysis of modelled bone SLA by Levy et al. [60] , hydroxyapatite implants by structures. The trabecular bone structure from the Chu et al. [19] , hydroxyapatite scaffolds using the human proximal femur was modelled to investigate ModelMaker II RP system [61] , and biomimetic its mechanical integrity for managing issues such as and composite three-dimensional polymer-ceramic osteoporosis or implant fixation. Mechanical tests of scaffolds using three-dimensional printing (3DP) scaled physical models [fused deposition modelling (see section 4.3 for a short definition) [62] .
(FDM, an RP technique based on the extrusion of a
In recent years there has been increasing emphasis semi-molten plastic filament) and stereolithography placed on the research of RM for the direct pro-(SLA)] correlated with the results of a digital finite duction of in vivo devices. Several parties have element analysis conducted through CAD.
investigated the adaptation of existing commer-Current CAD systems are geared towards the cialized RP processes for producing in vivo devices, design of parts manufactured by traditional manuas described in the following subsections according facturing technologies and hence represent a solid to process types. object by its surface [57] . Researchers at the Nanyang Technological University have taken a step forward 4.1 Stereolithography for in vivo devices in exploring a new approach to modelling complex objects. This is based on NURBS-based volume mod-Stereolithography is an RP technique based on the selective curing of a photosensitive polymer resin. elling which not only represents the surface boundary but also the interior of a three-dimensional SLA is the most developed commercial RP process, its development began in the early 1980s, and it is object. The key idea of the NURBS-based volume modelling is to exploit the flexibility of NURBS mod-capable of high degrees of accuracy (±0.005 XY, ±0.002 Z ). However, traditional SLA materials con-elling and use the voxelized NURBS volumes as components for constructing complex objects, in tain toxic components that prohibit their application for in vivo use. Commercial SLA materials that particular with respect to medical applications [57, 58] . Valid STL file (the input format required by may be used in limited bodily fluid exposure have emerged, but there is none for in vivo use. Sub-most RP processes) generation through volume modelling and isosurface extraction makes the sequently, applications for implant production have butadiene-styrene (ABS) test specimens were generdevices ated using a road width (distance between consecutive filaments) of 0.315 mm, a slice thickness of Fused deposition modelling is an RP technique based on the extrusion of a semi-molten plastic 0.254 mm, and a varied raster gap of 0-0.5 mm in increments of 0.05 mm. Micrographs indicated that filament. It is an uncomplicated and reliable process and has been the subject of several investigations three-dimensional interconnecting pore structures existed within specimens. It was noted that the raster regarding use with different biocompatible materials. The porosity of FDM parts is easily altered according gap settings had a major influence on the microstructure of the specimens. Porosity values ranged to the raster pattern utilized, but functionally graded material (FGM) applications are inherently limited between 22 and 68 per cent, while compressive strength values ranged between 5 and 20 MPa. by the material format (filament).
Kalita et al. [66] investigated the development and fabrication of controlled-porosity structures using 4.3 Three-dimensional printing for in vivo polypropylene (PP) polymer and tricalcium phosdevices phate (TCP) ceramic, employing FDM for the healthy ingrowth of bone cells. Samples with 36 per cent Three-dimensional printing (3DP) is an RP process operating by the selective deposition of a binding volume porosity and an average pore size of 160 mm showed the best compressive strength of 12.7 MPa, liquid onto a powdered material to form a solid mass [70] . The 3DP process was developed at the which lies in the lower range of properties reported for trabecular bone. The results showed that samples Massachusetts Institute of Technology and has subsequently been licensed to machine producers [52, were non-toxic and also supported excellent cell attachment and growth during the first 2 weeks of in 71, 72]. This process has been subject to considerable investigations for RM, in particular for scaffolds vitro (simulation of conditions inside a living organism) studies.
and drug delivery applications [73, 74] . The process has the potential to incorporate different material Hutmacher [67] reported the fabrication of bone scaffolds for complex craniofacial skeletal recon-options owing to the flexibility of the material format (liquid and powder). The material format may also struction utilizing medical imaging, computational modelling, and FDM. The study indicated that the facilitate the possibility of functionally graded materials (FGMs), but may also be the source of difficult-use of polycaprolactone (PCL) scaffolds produced by FDM for the reconstruction of craniofacial defects ies for complex internal structures owing to powder entrapment. resulted in higher amounts of new bone ingrowth than clinically used poly(l-lactic acid)/poly(d-lactic
Lam et al. [75] investigated the development of scaffolds using 3DP. A blend of starch-based polymer acid) (PLLA/PDLA) 70/30 foil. Results indicated that scaffolds coated with bone marrow resulted in higher powders (50 per cent cornstarch, 30 per cent dextran, and 20 per cent gelatin) was developed for use in bone formation.
Zein et al. [68] investigated the effect of process various tissue engineering applications. The scaffolds were built and characterized for several properties, variation in the fabrication of PCL porous scaffolds using FDM for an intended application in bone tissue including porosity, compression, and water absorption, using scanning electron microscopy (SEM) and engineering. Various processing parameters were used to fabricate scaffolds with a channel size of differential scanning calorimetry (DSC). Five different designs were fabricated and post-processed 160-700 mm and a porosity of 48-77 per cent. A great variation in mechanical properties was demon-by infiltrating scaffolds with different amounts of copolymer solution, with half of them being soaked strated in accordance with varied porosity (compressive stiffness 4-77 MPa, yield strength 0.4-in deionized water for 10 min and dried to enhance the mechanical and chemical properties. As a result Tan et al. [82] investigated the use of a polyether of the post-processing employed, the shrinkage ether ketone (PEEK) and hydroxyapatite (HA) comranged between 2 and 12 per cent depending on the posite with different percentage composition ratios design. Microporosity values decreased after infilusing a commercial SLS machine for the intended tration because the copolymer infiltrated the microapplication of scaffold-guided tissue engineering. pores and voids. A linear and inversely proportional
The laser power, part bed temperature, and scan relationship between compressive stiffness and speed were the three SLS parameters investigated. porosity was found.
Results indicated that 40%HA was an ideal com-Other research work has investigated the use of position to produce structures with good integrity. three-dimensional printing for the fabrication of cus-Optimum SLS processing occurred at a low part bed tomized polymeric drug delivery systems to overtemperature complemented by a higher laser power. come the drawback of decreased drug release rate as Further studies [83] have been conducted with varia function of time. A drug concentration profile is ous biodegradable polymers including polycaprogenerated in a computer model, which is produced lactone (PCL) and Poly(l-lactic acid) (PLLA) for by 3DP. By this means, complex drug delivery regimes applications where anchorage-dependent cells rely can create multiple drugs or the multiphase release on the use of temporary three-dimensional scaffolds of a single drug.
to guide cell proliferation. This study has ascertained the possibility of using biocompatible polymers in
Selective laser sintering for in vivo devices
SLS. The technique enables the production of the well-defined pore interconnectivity required by Selective laser sintering (SLS) is a commercialized RP tissue engineering, which gives SLS the edge over technique that operates by the selective melting and conventional manual-based fabrication techniques. fusion of a powdered material by laser exposure. SLS Das et al. [84, 85] investigated the use of SLS with was developed in the late 1980s at the Mechanical nylon-6 to fabricate scaffolds with periodic and Engineering Department of the University of Texas biomimetic internal architecture which had been at Austin [35, 76, 77] . The process has a relatively produced by computational design methods with large range of materials that may be processed, but intended application for hard tissue engineering equipment and ancillary costs are high.
scaffolds. In vitro results indicated that 51-65 per Pioneering work by Lee and Barlow [78, 79] on cent of the pore space was occupied by the regenerpolymer-coated calcium phosphate for the fabriated bone, which is consistent with monolithic cation of artificial bone implants first revealed the hydroxyapatite scaffolds. The level of cell viability potential capabilities of employing SLS for in vivo was less than 70 per cent on average. Studies have devices.
also indicated the possibility of constructing func-Improvements in the SLS process are expected and tionally tailored tissue scaffolds in a single step via are being researched to enable RM to be used for the SLS of multiple materials, which would enable the production of desired scaffolds for tissue engineersimultaneous growth of multiple tissues, tissue ing. These include developing the ability to create interfaces, and blood vessels. smaller features by using a smaller laser spot size, Chua et al. [86, 87] reported the fabrication of powder size, and thinner layer thickness [80] .
poly(vinyl alcohol) (PVA) and hydroxyapatite (HA) Cruz and Simoes [46] reported the production of composites by SLS to fabricate three-dimensional poly(l-lactide)/hydroxyapatite composite (PLLA/HA) tissue engineering scaffold structures. The PVA/HA implants for lower load bearing applications using powder showed promising sintering results. Simu-SLS. Authors have emphasized that the production lated body fluid (SBF), which has an ionic concenof implants using RM technologies is still at an tration and pH almost equal to those of human blood embryonic stage and far from the industrial proplasma, was used to analyse chemical and morphoduction stage.
logical changes of HA in the test specimens by imitat-Rimell and Marquis [81] reported the investigation ing actual physiological interaction between the HA of SLS using ultrahigh molecular weight polyethylsurface and the implant site. Bioactivity analysis indiene (UHMWPE) for clinical applications including cated the presence of hydroxycarbonate apatite patient-tailored prostheses. This study raised a (HCA) on specimens soaked in SBF. number of concerns, including material shrinkage, Goodridge et al. [88] reported a study of the direct the porosity formed, degradation in terms of chain SLS of both apatite-mullite glass ceramic and scission, crosslinking, and oxidation. It was conhydroxyapatite (HA) with lower-melting calcium cluded that the development of new powders with increased density was required. sodium phosphate (CNP -resorbable glass) for bone replacement implants. Success with the glass cer-cations with varying degrees of success. Most of these processes possess different limitations that derive amic was observed with a powder size range between 0-45 mm and 45-90 mm. HA-CNP was sintered into from their development for use as models/prototype production processes and not as dedicated manufac-10 mm×10 mm×5 mm blocks by direct SLS. However, no success was achieved in producing samples turing technologies for the RM of specific in vivo devices. Along with those discussed in the previous of similar strength to typical bone.
Savalani and Harris [49] studied the effect of vary-sections, other limitations include the following. ing particle size of a commercial hydroxyapatite-1. Among the greatest restrictions are the current reinforced polyethylene (HA-HDPE) bioactive polymaterial limitations -very few biocompatible or mer/ceramic composite material for the direct probioactive materials are currently available that duction of bioactive implants and tissue scaffold have undergone the necessary development for structures using selective laser sintering. It was found regulatory use. The majority of RP/RM materials that particles within 100 mm fused irrespective of the developed and introduced to date have been particle morphology. Further studies [89] illustrated largely based upon improvements in mechanical the effects on the degree of sintering of HAPEXA of integrity. a varying laser power and scan speed. Preforms fabri-2. Several current processes rely on high temperacated at various power and speed settings resulted tures during and after manufacture. Heating to in a porous or relatively dense morphology. elevated temperatures influences the integrity of Chua et al. [90] reported the production of scaffold several biomaterials, some even beyond body structures with consistent and reproducible microartemperature levels. chitectures by using a scaffold library algorithm 3. Little attention has been paid to the RM of sterile together with SLS for various tissue engineering products, either in terms of their manufacture scaffolds. The scaffolds were not built with a biomat-(clean room compatible processes) or in terms erial but with commercial SLS nylon (DuraformTM), of the ability of materials to withstand postsince this particular research focused largely on manufacture sterilization processes. assessing the design possibilities. Pore sizes of 4. Paramount to the full exploitation of RM for in between 0.616 and 0.905 mm were fabricated. Howvivo devices is the integration of complex internal ever, removing the loose powder within the pores structures and variable composition. There have proved to be difficult.
been several developments regarding the inte-Williams et al. [91] experimented with the SLS of gration of such capabilities in the production propolycaprolactone (PCL), which is bioresorbable, with cess, but there have been relatively few related potential applications for bone and cartilage repair. developments in the design capabilities for this. Scaffold designs were produced by computational Three-dimensional CAD is a primary enabling methods, and porous PCL structures were fabricated technology in RM, and there has been little using SLS. The compressive modulus and yield advance in capabilities for internal design, both strength values ranged from 52 to 67 MPa and from geometrical and compositional, through CAD 2.0 to 3.2 MPa respectively, lying within the lower software. range of properties reported for human trabecular 5. Removal of powders -powder-based techniques bone. It was concluded that the integration of com-(e.g. SLS and 3DP) require post-processing techputational scaffold design and layer manufacturing niques to enable the removal of trapped powder. techniques could prove highly useful for the con-This process may be a limiting factor of the struction of scaffolds that have anatomy-specific internal architecture that can be produced. Moreexterior architecture derived from patient CT or MRI over, it may also result in reduced biocompatidata and an interior porous architecture derived bility of in vivo devices owing to the media from computational design optimization.
containing leach-out products which result in det-Other research work conducted by Nanyang rimental cellular response and, in turn, reduced Technological University Singapore for healthcare cell viability. applications leans towards the production of drug delivery devices [92] [93] [94] [95] [96] .
NOVEL RM TECHNOLOGIES 4.Limitations of traditional RP/RM processes

Some of the established commercial RP processes
The investigation of novel RM technologies for in vivo devices has been prompted by the limitations have been investigated for the RM of in vivo appli- Mironov et al. [102] reported the concept, practical aspects, and development of an RM cell printer for been used in other applications for modelling, reverse engineering, etc. Novel techniques developed direct soft tissue engineering. The cell printer aims to overcome the limitation of RP techniques, which by various research groups include the following.
The Bioplotter, invented at the Freiburg Materials are not capable of precisely placing cells aggregated into a printed scaffold. The process involves three Research Centre and developed by Envisiontech GmbH, is a commercially available system that incor-sequential steps: preprocessing or development of blueprints for organs; processing or actual organ porates cultures of the patient's own cells to build scaffold structures (see Fig. 3 ). The principle of the printing; and post-processing or organ conditioning and accelerated organ maturation. Cell or cell aggre-process involves a plotting material (with cells) being dispensed through a nozzle by air-pressure control gates are placed in a three-dimensional gel with sequential maturation of the three-dimensional into a bath of liquid with matching density and polarities, thus preventing gravity-induced structural organs using a thermoreversible gel or matrix that solidifies upon fusion. Thus far, a cell printer has collapse [97] [98] [99] . This technique has been used by Landers et al. [100] who reported the building of been developed that could fuse closely placed cell aggregates and heart mesenchymal (cushion tissue) scaffolds derived from thermoreversible hydrogels (a polymer network with high water content) for soft fragments into ring and tube-like structures in threedimensional gel (see Fig. 4 ). tissue engineering. This work produced hydrogel scaffolds with a specific external shape and a defined Xiong et al. [103, 104] reported the fabrication of porous poly(l-lactic acid) (PLLA) scaffolds using an internal pore structure. The geometry of a nose was fabricated to demonstrate the potential for soft tissue RM technique termed precise extrusion manufacturing (PEM). This extrusion-based system feeds a implant generation. Further studies have indicated the need for more basic research to improve the per-heated thermoplastic material onto a working platform using a special sprayer extruder for precise formance of hydrogel scaffolds in tissue engineering [101] .
extrusion. The extruder is designed with compressed air and a tie-in as opposed to the driving wheels used (MDM) system [104, 107, 108] , has been investigated for the fabrication of bone tissue engineering in a commercial FDM machine. The extruder is controlled using software that will not scan the contour scaffolds with gradient materials and morphologies. Further investigations have led to the possibility of but only scan the filling-in network of the object, which ensures an open porous architecture of the extruding poly(e-caprolactone) (PCL) for the freeform construction of three-dimensional tissue scaf-scaffolds. The process builds physical objects in a layer-by-layer fashion directly driven by three-folds at room temperature and low pressures [12] .
Wang et al. [109] reported the fabrication of cellu-dimensional CAD data. The scaffolds exhibited controlled porous architectures of 200-500 mm. It is lar PCL scaffolds using a novel precision extruding deposition (PED) technique which involves a mini-made clear that the design of scaffold material and the modelling techniques of porous scaffolds are extruder system delivering the PCL in a fused form through the deposition nozzle. The major difference pivotal questions. Further studies on degradation evaluation in vitro showed that a 90 per cent mass between the PED process and the conventional FDM process is that the scaffolding material can be loss was experienced after samples were immersed in pancrelipase phosphate buffer saline (PBS) for 2 directly deposited through the PED process without involving filament preparation. Scaffolds with a con-weeks. Based on the enzyme activity, it was estimated that those PLLA scaffolds would degrade almost trolled pore size of 250 mm and designed structural orientations were fabricated. Further work has been wholly within 100 days in vivo, which was considered appropriate for the bone repair process.
conducted by Darling and Sun [110] to characterize the microstructure of scaffolds made using PED. Xiong et al. [104, 105] reported the fabrication of poly(l-lactic acid)/tricalcium phosphate (PLA-TCP)
The micro-CT imaged pores were between 200 and 300 mm, the optimal size suggested for tissue scaf-scaffolds for tissue engineering using a technique termed low-temperature deposition manufacturing folds. The greatest asset of samples manufactured by this technique is the possibility of obtaining porous (LDM) (see Fig. 5 ). LDM is based on a droplet assembly process that may maintain the bioactivity interconnectivity greater than 98 per cent.
Ciardelli et al. [111] investigated the testing and of scaffold materials because of its non-heating liquefying process compared with RP technologies fabrication of poly(e-caprolactone) (PCL) and poly(ecaprolactone)-poly(oxyethylene)-poly(e-caprolac-such as SLA, SLS, and FDM which work at high temperatures. A composite of PLA and TCP was used to tone) (PCL-POE-PCL) scaffolds using a pressureassisted microsyringe (PAM) technique and SLS. form a bone scaffold. These scaffolds possessed a high porosity level of 90 per cent with controlled Scaffolds were successfully produced using these two means of fabrication. Emphasis was placed on the interconnectivity and macrocellular and microcellular morphology while retaining mechanical property substantially different structure resolution achievable in the two processes, as PAM allows the fabri-values close to human spongy bones. In vivo results showed good bone conductivity and appropriate cation of fine-featured microstructures down to 5-10 mm wide and 5 mm high, whereas SLS structures biodegradation property for bone repair. Concurrent studies with regard to the PLA degradation rate are demonstrated a resolution of about 300 mm height ×700 mm width. being carried out by several researchers including Kim et al. [106] .
Vozzi et al. [112] reported the fabrication of poly(d,l-lactide-co-glycolide) (PLGA) scaffolds with An extension of the LDM process, namely the multinozzle (four-nozzle) deposition manufacturing a feature size of approximately 10-30 mm using a
Fig. 5
Low-temperature deposition manufacturing process [105] pressure-assisted microsyringe (PAM). PAM is based for porous bone grafts using robocasting. Robocasting is an additive freeform fabrication technique on the use of a microsyringe that utilizes a computerthat robotically deposits ceramic suspensions for the controlled, three-axis micropositioner, which allows fabrication of HA structures with controlled internal the control of motor speeds and position. A PLGA architectures. Structures with controlled pores in the solution is deposited from the glass capillary needle size range from 100 mm to 1 mm have been proof a syringe by the application of a constant pressure, duced. resulting in a controlled polymer deposition. Prior attempts to manufacture scaffolds using microsyringe techniques have achieved resolutions of 50 mm 6 BIOMATERIALS FOR RM TECHNIQUES [113] . The adapted PAM technique enables a resolution of 10 mm in the horizontal direction and For the development of novel RM techniques for in 5-10 mm in the vertical direction. Although this vivo devices, it is essential that it be accompanied system is highly automated and provides the poswith appropriate material development. A relatively sibility of dynamically altering polymer composition, small amount of research has been conducted in the a limited number of materials can be used owing to field of biomaterials for RM. the narrow range of viscosities that can be employed Tian et al. [117] demonstrated the preparation and to obtain high-resolution structures. characterization of HA suspensions by wet chemical Ang et al. [114] reported the fabrication of threesynthesis for layer manufacturing in 2002. dimensional chitosan (a naturally occurring amino-Pfister et al. [118] reported the development and polysaccharide) and HA (0, 20, and 40%HA) scaffolds use of zinc polycarboxylate ionomers as a powder with regular and reproducible macropore architecmaterial for 3DP. These ionomers demonstrated ture using a robotic dispensing system. The system stiffness and water-resistant properties without was an extrusion-based system consisting of a comrequiring post-printing treatments. puter-guided desktop robot and a single-component
The Bioplotter technology allows the incorporation pneumatic dispenser. In vitro cell culture studies of natural materials including aqueous solution and indicated that the scaffolds were capable of cell seedpastes. However, the key feature of this technology ing and strong proliferation throughout the culture is the three-dimensional dispensing of liquids and period.
pastes onto a plotting medium with similar density Woodfield et al. [115] reported the production to compensate for gravity forces through buoyancy of three-dimensional biodegradable poly(ethylene [99, 100] . As a consequence, complex structures glycol)terephthalate-poly(butylene terephthalate) may be produced without requiring the construction (PEGT/PBT) block copolymer scaffolds with a 100 of sacrificial support structures which are typical per cent interconnecting pore network using a threefor most of the other RP/RM technologies. This effect dimensional fibre-deposition RM technique for can be further increased by using a thixotrope engineering of articular cartilage. The technique medium [99] . Moreover, in the presence of a temenabled the production of desired scaffold characterperature-controlled plotting medium, the solidifiistics by accurately controlling the deposition of cation of the material during plotting into the molten copolymer fibres from a pressure-driven medium can be caused by precipitation, phase transsyringe onto a computer-controlled x-y-z table. The ition, or chemical reaction. pressure-driven syringe unit contained thermo-
The low-temperature deposition manufacturing statically controlled heating rods capable of evenly (LDM) process requires the material to be fed in a conducting heat for uniform heating of the coslurry form. This material has to be able to perform polymer fibres. By varying PEGT/PBT composition, in a low-temperature environment below 0°C. Once porosity, and pore geometry, three-dimensional this material is deposited onto the surface, it freezes. deposited scaffolds were produced with a range of Hence, control over the glass transition temperature, mechanical properties. The equilibrium modulus melting temperature, and freezing temperature plays and dynamic stiffness ranged between 0.05-2.5 and an important role in the realization of this tech-0.16-4.33 MPa. These results were similar to native nology. articular cartilage (0.27 and 4.10 MPa). Further studies were needed in respect of the effects of scaffold composition and pore architecture on articular carti-7 CONCLUSIONS lage tissue formation.
Cesarano [116] reported the fabrication of In vivo devices have been, and contine to be, fabricated to replace or restore functions of living tissues. hydroxyapatite structures with controlled porosity 
